Skip to content

Making the Head and Neck Cancer-specific Patient Concerns Inventory (PCI-HN) available and reliable for patients who speak Hindi, Marathi, and Bengali.

Translation and validation of Head and Neck cancer-specific Patient Concerns Inventory (PCI-HN) in Indian vernacular languages Hindi, Marathi and Bengali. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094049
Enrollment
840
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C069- Malignant neoplasm of mouth, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All eligible consenting adult Head and neck cancer patients who have completed their curative treatment are on regular hospital follow-up.Disease free patients following head and neck cancer treatment, who are attending their routine clinic consultation. Patients who can read, write and understand Hindi / Marathi/ Bengali language by themselves.

Exclusion criteria

Exclusion criteria: Patients with cognitive impairment, psychiatric illness.Illiterate patients or visually impaired patients who cannot read by themselves. Patients who have been treated for thyroid and skull-based cancers. (PCI-HN).Patients on any form of palliative treatment for head and neck cancer (PCI-HN).

Design outcomes

Primary

MeasureTime frame
To perform translation of PCI-HN will be carried out in the native Indian population speaking Hindi, Marathi and Bengali. To test the translated version psychometrically through measures of statistical reliability (internal consistency and test-retest reliability). To find association between demographic factors and PCI-HN domains.Timepoint: The translated PCI checklist will be given to each person just once, and their answers will be recorded on that day. There is no need for any follow-up visits afterwards

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Sandeep Guarv

Tata Memorial Hospital

drsandeepgurav@gmail.com919769387712

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026